跳至主要内容
临床试验/ISRCTN27673620
ISRCTN27673620已完成不适用

Vitamin D replacement to prevent acute lung injury following oesophagectomy - a randomised placebo controlled trial

niversity of Birmingham (UK)0 个研究点目标入组 80 人开始时间: 2011年12月21日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
80

研究概览

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Planned transthoracic oesophagectomy for oesophageal carcinoma at a participating centre
  • 2. Aged over 18 years on day of first dose of investigational medicinal product (IMP)
  • 3. Ability to give written informed consent to participate in the study

排除标准

  • 1. Known intolerance of vitamin D
  • 2. Known sarcoidosis, hyperparathyroidism, or nephrolithiasis
  • 3. Taking more than 1000iu/day vitamin D supplementation in the month preceding enrolment
  • 4. Baseline serum corrected calcium >2.65 mmol/L
  • 5. Undergoing haemodialysis
  • 6. Pregnant or breastfeeding
  • 7. Taking cardiac glycoside, carbamazepine, phenobarbital, phenytoin, primidone or long-term immunosuppressant therapy
  • 8. Taking oral preparation containing > 10 micrograms vitamin D/day up to 2 months before first dose of IMP
  • 9. Diagnosis of COPD with an FEV1 less than 50% predicted or resting oxygen saturations of less 92%

研究者

发起方
niversity of Birmingham (UK)

相似试验